Critical Limb Ischemia: Current Trends and Future Directions - sprookjes - yvandenbroek - TriplyDB

Critical Limb Ischemia: Current Trends and Future Directions

Critical Limb Ischemia: Current Trends and Future Directions

http://www.wikidata.org/entity/Q26767021

about

Safety and Effectiveness of Bone Marrow Cell Concentrate in the Treatment of Chronic Critical Limb Ischemia Utilizing a Rapid Point-of-Care System.Impact of diabetes on outcome in critical limb ischemia with tissue loss: a large-scaled routine data analysis.Long-Term Follow-up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia.Trimodal rescue of hind limb ischemia with growth factors, cells, and nanocarriers: fundamentals to clinical trials.Promoting Limb Salvage through Multi-Disciplinary Care of the Diabetic Patient.Decision-Making in Critical Limb Ischemia: A Markov Simulation.Deletion of TXNIP Mitigates High-Fat Diet-Impaired Angiogenesis and Prevents Inflammation in a Mouse Model of Critical Limb Ischemia.Growth Differentiation Factor 15 Is Associated With Major Amputation and Mortality in Patients With Peripheral Artery Disease.Predictive Parameters for Clinical Outcome in Patients with Critical Limb Ischemia Who Underwent Percutaneous Transluminal Angioplasty (PTA): A Systematic Review.Ghrelin, MicroRNAs, and Critical Limb Ischemia: Hungering for a Novel Treatment Option.Cell therapy for peripheral artery disease.Prostanoids for critical limb ischaemia.Lifelong limb preservation: A patient-centered description of lower extremity arterial reconstruction outcomes.An endovascular model of ischemic myopathy from peripheral arterial disease.Critical limb ischaemia: artery repair.Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

P2860

Q36279463-F7EB6BAA-806B-4A41-A35C-CA158FF6F680 Q36334782-73872B2C-3EFC-4D21-9183-E0E469913332 Q38378065-61A53005-DB07-41FD-A3AA-EE909B7256CB Q39240834-6EBF20A8-1BEF-4F81-814A-685FF2F0BE07 Q39343007-D8C4FF41-C69D-4075-A96F-20D8A191D1FD Q40121915-AE56F99A-EE20-4075-92EB-B24E8FECE1D6 Q41662846-BC72553A-1F37-4BB4-84C5-CFF4E9C68FF3 Q42373707-6A4DBD89-B84A-499F-B1FC-45F6DE36F11C Q47169663-282D7174-96AB-4EB6-B108-9303BEC69C5B Q49561459-B39F5E49-5DD1-40AC-8397-C8D35FCA529C Q49917431-5C001C54-91D6-4B07-A2D0-35F834009CAB Q50109602-F2B03D3A-7C35-4A34-BE1D-C99F534D5032 Q50649133-A1183836-3947-4E30-BEB9-8C646042391C Q51148798-B28AAD9B-0E9C-4024-9087-475654F50248 Q51802774-8519A00F-351D-4C00-A6CC-A117B657F7F2 Q56384060-386D643A-F3E2-40EF-91F4-5280BA9219F1 Q57621177-8EEE1A8A-735A-45C1-9263-FF37555AB775

P2860

Critical Limb Ischemia: Current Trends and Future Directions

http://www.wikidata.org/entity/Q26767021

description

2016 nî lūn-bûn

@nan

2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Critical Limb Ischemia: Current Trends and Future Directions

@ast

Critical Limb Ischemia: Current Trends and Future Directions

@en

Critical Limb Ischemia: Current Trends and Future Directions

@nl

type

label

Critical Limb Ischemia: Current Trends and Future Directions

@ast

Critical Limb Ischemia: Current Trends and Future Directions

@en

Critical Limb Ischemia: Current Trends and Future Directions

@nl

prefLabel

Critical Limb Ischemia: Current Trends and Future Directions

@ast

Critical Limb Ischemia: Current Trends and Future Directions

@en

Critical Limb Ischemia: Current Trends and Future Directions

@nl

P1433

Q26767021-AA9741C1-B25F-488D-8787-3B84663938E1

P1476

Q26767021-73AB3C43-AD18-4AF2-8C2B-A0EF4D57753B

P2093

Q26767021-16DA69CE-13EC-4791-B934-EC5D04C5A783

Q26767021-973CAC99-AA49-4D0F-933E-D17023217CA3

P275

Q26767021-249F8184-E027-4212-9C97-788A8C47AF2E

P2860

Q26767021-055F2208-D7DE-4233-A657-0099D864D554

Q26767021-0B7A0C82-6883-43FF-AC11-17B1B92D1721

Q26767021-10E8FEC4-30BC-4FA0-A71E-84C53DF181DE

Q26767021-1111C9E8-1F03-4FF7-8CD9-A02814CCAC92

Q26767021-15B2763E-FE86-40F9-B0BE-554E25B96AC4

Q26767021-1ADBC9F4-5223-4AB5-9DFD-AE60CED30F80

Q26767021-1D426231-8F5E-43BD-A9C0-08C74D1628D7

Q26767021-1E3F795F-35C8-4AF0-90D1-EA07CA8CAAFD

Q26767021-1F937422-A663-47C1-8627-A436C1092B5A

Q26767021-277B0A8F-DCB5-49B0-AE8E-58F555D422F9

P304

Q26767021-FA7202FE-5750-43F2-9B75-D909872E85CA

P31

Q26767021-399B7361-D0B2-43AB-82E6-2C8EAEBEEFFD

Q26767021-8A8A066C-949B-4E2B-9E35-924D6D1F50E2

P356

Q26767021-E6B1A3A7-E473-4BA4-87A8-E7EE668083BA

P407

Q26767021-5FBD713F-9F71-428F-8AEE-A49D9C2DBF0E

P433

Q26767021-F5802011-85E7-4B88-9A15-B2097FD60A04

P478

Q26767021-81CA1DAB-EA96-44A0-92F5-D00B4BBF7DF4

P50

Q26767021-0CC0E340-F939-47B0-BAB0-0C35A55160E8

Q26767021-F6A5DAF1-6B35-4301-8FA8-8D37E60FDAEB

P5008

Q26767021-AB40BF06-7040-4421-B7AD-8EF108615E26

P577

Q26767021-58FD3535-2B90-4417-AEFB-1FD22E624A71

Q26767021-6A8DA73A-1EAE-4114-B197-D3A978C52C5A

P698

Q26767021-ACB2F0A7-EC53-4A23-B6F0-F22DBCD49E6D

P921

Q26767021-35A37153-5145-4CE3-8AA5-3AEFEEA9C71D

Q26767021-7DC186DF-62CE-4DF9-A231-EFDA7995B3BF

Q26767021-D04086AC-8B34-44B2-8E0D-32D70503ED5D

P932

Q26767021-06615236-46C3-4EDE-86B6-1CC0ED061F4D

P356

JAHA.115.002938

P1433

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

P1476

Critical Limb Ischemia: Current Trends and Future Directions

@en

P2093

Frans L Moll

http://www.w3.org/2001/XMLSchema#string

Michael S Conte

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database.

Chapter III: Management of cardiovascular risk factors and medical therapy

Defining risks and predicting adverse events after lower extremity bypass for critical limb ischemia

Bone Marrow derived Cell Therapy in Critical Limb Ischemia: A Meta-analysis of Randomized Placebo Controlled Trials

Peripheral arterial disease detection, awareness, and treatment in primary care

Prior failed ipsilateral percutaneous endovascular intervention in patients with critical limb ischemia predicts poor outcome after lower extremity bypass

Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia.

Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data.

Critical limb ischemia

Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC).

P304

e002938

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/JAHA.115.002938

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Marianne C. Verhaar

P5008

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2016-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26908409

http://www.w3.org/2001/XMLSchema#string

P921

peripheral artery disease

preventive health services

P932

4802465

http://www.w3.org/2001/XMLSchema#string